Evidence map›Paper›PMID 30181393›Full record

ArticleMolecular and cellular biology2018

Fra-2 Expression in Osteoblasts Regulates Systemic Inflammation and Lung Injury through Osteopontin.

Yubin Luo, Bettina Grötsch, Nicole Hannemann, Maria Jimenez, Natacha Ipseiz, Ozge Uluckan, Nengyu Lin, Georg Schett, Erwin F Wagner, Aline Bozec

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Progress in the Study of Fra-2 in Respiratory Diseases.International journal of molecular sciences · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Osteopontin in Bone Metabolism and Bone Diseases.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Yubin Luo *Friedrich-Alexander University Erlangen-Nürnberg, Department of Internal Medicine 3 Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany.
Bettina Grötsch *Friedrich-Alexander University Erlangen-Nürnberg, Department of Internal Medicine 3 Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany.
Nicole HannemannFriedrich-Alexander University Erlangen-Nürnberg, Department of Internal Medicine 3 Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany.
Maria JimenezGenes, Development and Disease Group, F-BBVA-CNIO Cancer Cell Biology Program, Spanish National Cancer Research Center, Madrid, Spain.
Natacha IpseizFriedrich-Alexander University Erlangen-Nürnberg, Department of Internal Medicine 3 Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany.
Ozge UluckanGenes, Development and Disease Group, F-BBVA-CNIO Cancer Cell Biology Program, Spanish National Cancer Research Center, Madrid, Spain.
Nengyu LinFriedrich-Alexander University Erlangen-Nürnberg, Department of Internal Medicine 3 Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany.
Georg SchettFriedrich-Alexander University Erlangen-Nürnberg, Department of Internal Medicine 3 Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany.
Erwin F WagnerGenes, Development and Disease Group, F-BBVA-CNIO Cancer Cell Biology Program, Spanish National Cancer Research Center, Madrid, Spain.
Aline BozecFriedrich-Alexander University Erlangen-Nürnberg, Department of Internal Medicine 3 Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany aline.bozec@uk-erlangen.de.
Universitätsklinikum Erlangen · DECentro de Investigación del Cáncer · ESSichuan University · CNSpanish National Cancer Research Centre · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory responses require mobilization of innate immune cells from the bone marrow. The functionality of this process depends on the state of the bone marrow microenvironment. We therefore hypothesized that molecular changes in osteoblasts, which are essential stromal cells of the bone marrow microenvironment, influence the inflammatory response. Here, we show that osteoblast-specific expression of the AP-1 transcription factor Fra-2 (Fra-2

Indexed as

AnimalsBone MarrowCells, CulturedCytokinesFos-Related Antigen-2Immunity, InnateInflammationLipopolysaccharidesLung InjuryMiceNeutrophilsOsteoblastsOsteopontinTranscription Factor AP-1CytokinesFosl2 protein, mouseFos-Related Antigen-2LipopolysaccharidesOsteopontinTranscription Factor AP-1bone nicheFra-2Fra-2/AP-1lung injuryosteoblastsosteopontinsystemic inflammation

Identifiers

PMID30181393
PMCPMC6206458
OpenAlexW2891617590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.